ClinConnect ClinConnect Logo
Search / Trial NCT04298216

Transhepatic Versus Subcostal Views to Assess Inferior Vena Cava Variation in Pediatric Patients

Launched by STANFORD UNIVERSITY · Mar 4, 2020

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at two different ways to use ultrasound to see a part of the heart called the inferior vena cava (IVC) in children. Usually, doctors place the ultrasound probe below the chest, which can be uncomfortable for kids. This study is exploring a new method where the probe is placed under the arm, which may be more comfortable for young patients. The goal is to see if this new position is just as effective for getting a clear view of the heart.

To be eligible to participate, children must be between 2 and 18 years old and need to have permission from their parents. They will need to be stable and not in need of emergency surgery. Participants can expect a comfortable ultrasound experience, and the study is happening at a specific medical facility. This trial is not yet recruiting participants, but it aims to improve how doctors can assess heart health in children.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Be between ages of 2-18 years of age
  • 2. Have parental consent
  • 3. located at an inpatient/outpatient facility at LPCH
  • 4. Be hemodynamically stable
  • Exclusion Criteria:
  • 1. Emergent Surgical Procedures
  • 2. BMI greater than 24

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials